Global Cell Therapy CDMO Market 2022 by Company, Regions, Type and Application, Forecast to 2028
According to our (Global Info Research) latest study, the global Cell Therapy CDMO market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Cell Therapy CDMO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2022, are provided.
Key Features:
Global Cell Therapy CDMO market size and forecasts, in consumption value ($ Million), 2017-2028
Global Cell Therapy CDMO market size and forecasts by region and country, in consumption value ($ Million), 2017-2028
Global Cell Therapy CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2017-2028
Global Cell Therapy CDMO market shares of main players, in revenue ($ Million), 2017-2022
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell Therapy CDMO
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell Therapy CDMO market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Charles River, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies and Exothera, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Cell Therapy CDMO market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Cell Therapy CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell Therapy CDMO, with revenue, gross margin and global market share of Cell Therapy CDMO from 2017 to 2022.
Chapter 3, the Cell Therapy CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Cell Therapy CDMO market forecast, by regions, type and application, with consumption value, from 2023 to 2028.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell Therapy CDMO.
Chapter 13, to describe Cell Therapy CDMO research findings and conclusion.
This report is a detailed and comprehensive analysis for global Cell Therapy CDMO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2022, are provided.
Key Features:
Global Cell Therapy CDMO market size and forecasts, in consumption value ($ Million), 2017-2028
Global Cell Therapy CDMO market size and forecasts by region and country, in consumption value ($ Million), 2017-2028
Global Cell Therapy CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2017-2028
Global Cell Therapy CDMO market shares of main players, in revenue ($ Million), 2017-2022
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell Therapy CDMO
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell Therapy CDMO market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Charles River, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies and Exothera, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Cell Therapy CDMO market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Stem Cell
- Non-Stem Cell
- Commercial
- Academic Research
- Others
- Charles River
- The Discovery Labs
- BIOCENTRIQ
- FUJIFILM Diosynth Biotechnologies
- Exothera
- WuXi AppTec
- Pharmaron
- OBiO
- Cell Therapies
- AGC Biologics
- Cytiva
- Helixmith
- ThermoGenesis
- Anemocyte
- Thermo Fisher Scientific
- CBM
- Bio Elpida
- Genezen
- CCRM
- RoslinCT
- GenScript ProBio
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Cell Therapy CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell Therapy CDMO, with revenue, gross margin and global market share of Cell Therapy CDMO from 2017 to 2022.
Chapter 3, the Cell Therapy CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Cell Therapy CDMO market forecast, by regions, type and application, with consumption value, from 2023 to 2028.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell Therapy CDMO.
Chapter 13, to describe Cell Therapy CDMO research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Cell Therapy CDMO
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cell Therapy CDMO by Type
1.3.1 Overview: Global Cell Therapy CDMO Market Size by Type: 2017 Versus 2021 Versus 2028
1.3.2 Global Cell Therapy CDMO Consumption Value Market Share by Type in 2021
1.3.3 Stem Cell
1.3.4 Non-Stem Cell
1.4 Global Cell Therapy CDMO Market by Application
1.4.1 Overview: Global Cell Therapy CDMO Market Size by Application: 2017 Versus 2021 Versus 2028
1.4.2 Commercial
1.4.3 Academic Research
1.4.4 Others
1.5 Global Cell Therapy CDMO Market Size & Forecast
1.6 Global Cell Therapy CDMO Market Size and Forecast by Region
1.6.1 Global Cell Therapy CDMO Market Size by Region: 2017 VS 2021 VS 2028
1.6.2 Global Cell Therapy CDMO Market Size by Region, (2017-2028)
1.6.3 North America Cell Therapy CDMO Market Size and Prospect (2017-2028)
1.6.4 Europe Cell Therapy CDMO Market Size and Prospect (2017-2028)
1.6.5 Asia-Pacific Cell Therapy CDMO Market Size and Prospect (2017-2028)
1.6.6 South America Cell Therapy CDMO Market Size and Prospect (2017-2028)
1.6.7 Middle East and Africa Cell Therapy CDMO Market Size and Prospect (2017-2028)
2 COMPANY PROFILES
2.1 Charles River
2.1.1 Charles River Details
2.1.2 Charles River Major Business
2.1.3 Charles River Cell Therapy CDMO Product and Solutions
2.1.4 Charles River Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.1.5 Charles River Recent Developments and Future Plans
2.2 The Discovery Labs
2.2.1 The Discovery Labs Details
2.2.2 The Discovery Labs Major Business
2.2.3 The Discovery Labs Cell Therapy CDMO Product and Solutions
2.2.4 The Discovery Labs Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.2.5 The Discovery Labs Recent Developments and Future Plans
2.3 BIOCENTRIQ
2.3.1 BIOCENTRIQ Details
2.3.2 BIOCENTRIQ Major Business
2.3.3 BIOCENTRIQ Cell Therapy CDMO Product and Solutions
2.3.4 BIOCENTRIQ Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.3.5 BIOCENTRIQ Recent Developments and Future Plans
2.4 FUJIFILM Diosynth Biotechnologies
2.4.1 FUJIFILM Diosynth Biotechnologies Details
2.4.2 FUJIFILM Diosynth Biotechnologies Major Business
2.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product and Solutions
2.4.4 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.4.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.5 Exothera
2.5.1 Exothera Details
2.5.2 Exothera Major Business
2.5.3 Exothera Cell Therapy CDMO Product and Solutions
2.5.4 Exothera Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.5.5 Exothera Recent Developments and Future Plans
2.6 WuXi AppTec
2.6.1 WuXi AppTec Details
2.6.2 WuXi AppTec Major Business
2.6.3 WuXi AppTec Cell Therapy CDMO Product and Solutions
2.6.4 WuXi AppTec Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.6.5 WuXi AppTec Recent Developments and Future Plans
2.7 Pharmaron
2.7.1 Pharmaron Details
2.7.2 Pharmaron Major Business
2.7.3 Pharmaron Cell Therapy CDMO Product and Solutions
2.7.4 Pharmaron Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.7.5 Pharmaron Recent Developments and Future Plans
2.8 OBiO
2.8.1 OBiO Details
2.8.2 OBiO Major Business
2.8.3 OBiO Cell Therapy CDMO Product and Solutions
2.8.4 OBiO Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.8.5 OBiO Recent Developments and Future Plans
2.9 Cell Therapies
2.9.1 Cell Therapies Details
2.9.2 Cell Therapies Major Business
2.9.3 Cell Therapies Cell Therapy CDMO Product and Solutions
2.9.4 Cell Therapies Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.9.5 Cell Therapies Recent Developments and Future Plans
2.10 AGC Biologics
2.10.1 AGC Biologics Details
2.10.2 AGC Biologics Major Business
2.10.3 AGC Biologics Cell Therapy CDMO Product and Solutions
2.10.4 AGC Biologics Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.10.5 AGC Biologics Recent Developments and Future Plans
2.11 Cytiva
2.11.1 Cytiva Details
2.11.2 Cytiva Major Business
2.11.3 Cytiva Cell Therapy CDMO Product and Solutions
2.11.4 Cytiva Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.11.5 Cytiva Recent Developments and Future Plans
2.12 Helixmith
2.12.1 Helixmith Details
2.12.2 Helixmith Major Business
2.12.3 Helixmith Cell Therapy CDMO Product and Solutions
2.12.4 Helixmith Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.12.5 Helixmith Recent Developments and Future Plans
2.13 ThermoGenesis
2.13.1 ThermoGenesis Details
2.13.2 ThermoGenesis Major Business
2.13.3 ThermoGenesis Cell Therapy CDMO Product and Solutions
2.13.4 ThermoGenesis Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.13.5 ThermoGenesis Recent Developments and Future Plans
2.14 Anemocyte
2.14.1 Anemocyte Details
2.14.2 Anemocyte Major Business
2.14.3 Anemocyte Cell Therapy CDMO Product and Solutions
2.14.4 Anemocyte Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.14.5 Anemocyte Recent Developments and Future Plans
2.15 Thermo Fisher Scientific
2.15.1 Thermo Fisher Scientific Details
2.15.2 Thermo Fisher Scientific Major Business
2.15.3 Thermo Fisher Scientific Cell Therapy CDMO Product and Solutions
2.15.4 Thermo Fisher Scientific Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.15.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.16 CBM
2.16.1 CBM Details
2.16.2 CBM Major Business
2.16.3 CBM Cell Therapy CDMO Product and Solutions
2.16.4 CBM Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.16.5 CBM Recent Developments and Future Plans
2.17 Bio Elpida
2.17.1 Bio Elpida Details
2.17.2 Bio Elpida Major Business
2.17.3 Bio Elpida Cell Therapy CDMO Product and Solutions
2.17.4 Bio Elpida Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.17.5 Bio Elpida Recent Developments and Future Plans
2.18 Genezen
2.18.1 Genezen Details
2.18.2 Genezen Major Business
2.18.3 Genezen Cell Therapy CDMO Product and Solutions
2.18.4 Genezen Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.18.5 Genezen Recent Developments and Future Plans
2.19 CCRM
2.19.1 CCRM Details
2.19.2 CCRM Major Business
2.19.3 CCRM Cell Therapy CDMO Product and Solutions
2.19.4 CCRM Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.19.5 CCRM Recent Developments and Future Plans
2.20 RoslinCT
2.20.1 RoslinCT Details
2.20.2 RoslinCT Major Business
2.20.3 RoslinCT Cell Therapy CDMO Product and Solutions
2.20.4 RoslinCT Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.20.5 RoslinCT Recent Developments and Future Plans
2.21 GenScript ProBio
2.21.1 GenScript ProBio Details
2.21.2 GenScript ProBio Major Business
2.21.3 GenScript ProBio Cell Therapy CDMO Product and Solutions
2.21.4 GenScript ProBio Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.21.5 GenScript ProBio Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Cell Therapy CDMO Revenue and Share by Players (2017-2022)
3.2 Market Share Analysis (2021)
3.2.1 Market Share of Cell Therapy CDMO by Company Revenue
3.2.2 Top 3 Cell Therapy CDMO Players Market Share in 2021
3.2.3 Top 6 Cell Therapy CDMO Players Market Share in 2021
3.3 Cell Therapy CDMO Market: Overall Company Footprint Analysis
3.3.1 Cell Therapy CDMO Market: Region Footprint
3.3.2 Cell Therapy CDMO Market: Company Product Type Footprint
3.3.3 Cell Therapy CDMO Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Cell Therapy CDMO Consumption Value and Market Share by Type (2017-2022)
4.2 Global Cell Therapy CDMO Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Cell Therapy CDMO Consumption Value Market Share by Application (2017-2022)
5.2 Global Cell Therapy CDMO Market Forecast by Application (2023-2028)
6 NORTH AMERICA
6.1 North America Cell Therapy CDMO Consumption Value by Type (2017-2028)
6.2 North America Cell Therapy CDMO Consumption Value by Application (2017-2028)
6.3 North America Cell Therapy CDMO Market Size by Country
6.3.1 North America Cell Therapy CDMO Consumption Value by Country (2017-2028)
6.3.2 United States Cell Therapy CDMO Market Size and Forecast (2017-2028)
6.3.3 Canada Cell Therapy CDMO Market Size and Forecast (2017-2028)
6.3.4 Mexico Cell Therapy CDMO Market Size and Forecast (2017-2028)
7 EUROPE
7.1 Europe Cell Therapy CDMO Consumption Value by Type (2017-2028)
7.2 Europe Cell Therapy CDMO Consumption Value by Application (2017-2028)
7.3 Europe Cell Therapy CDMO Market Size by Country
7.3.1 Europe Cell Therapy CDMO Consumption Value by Country (2017-2028)
7.3.2 Germany Cell Therapy CDMO Market Size and Forecast (2017-2028)
7.3.3 France Cell Therapy CDMO Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Cell Therapy CDMO Market Size and Forecast (2017-2028)
7.3.5 Russia Cell Therapy CDMO Market Size and Forecast (2017-2028)
7.3.6 Italy Cell Therapy CDMO Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC
8.1 Asia-Pacific Cell Therapy CDMO Consumption Value by Type (2017-2028)
8.2 Asia-Pacific Cell Therapy CDMO Consumption Value by Application (2017-2028)
8.3 Asia-Pacific Cell Therapy CDMO Market Size by Region
8.3.1 Asia-Pacific Cell Therapy CDMO Consumption Value by Region (2017-2028)
8.3.2 China Cell Therapy CDMO Market Size and Forecast (2017-2028)
8.3.3 Japan Cell Therapy CDMO Market Size and Forecast (2017-2028)
8.3.4 South Korea Cell Therapy CDMO Market Size and Forecast (2017-2028)
8.3.5 India Cell Therapy CDMO Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Cell Therapy CDMO Market Size and Forecast (2017-2028)
8.3.7 Australia Cell Therapy CDMO Market Size and Forecast (2017-2028)
9 SOUTH AMERICA
9.1 South America Cell Therapy CDMO Consumption Value by Type (2017-2028)
9.2 South America Cell Therapy CDMO Consumption Value by Application (2017-2028)
9.3 South America Cell Therapy CDMO Market Size by Country
9.3.1 South America Cell Therapy CDMO Consumption Value by Country (2017-2028)
9.3.2 Brazil Cell Therapy CDMO Market Size and Forecast (2017-2028)
9.3.3 Argentina Cell Therapy CDMO Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cell Therapy CDMO Consumption Value by Type (2017-2028)
10.2 Middle East & Africa Cell Therapy CDMO Consumption Value by Application (2017-2028)
10.3 Middle East & Africa Cell Therapy CDMO Market Size by Country
10.3.1 Middle East & Africa Cell Therapy CDMO Consumption Value by Country (2017-2028)
10.3.2 Turkey Cell Therapy CDMO Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Cell Therapy CDMO Market Size and Forecast (2017-2028)
10.3.4 UAE Cell Therapy CDMO Market Size and Forecast (2017-2028)
11 MARKET DYNAMICS
11.1 Cell Therapy CDMO Market Drivers
11.2 Cell Therapy CDMO Market Restraints
11.3 Cell Therapy CDMO Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 UPSTREAM AND INDUSTRY CHAIN
12.1 Raw Material of Cell Therapy CDMO and Key Suppliers
12.2 Manufacturing Costs Percentage of Cell Therapy CDMO
12.3 Cell Therapy CDMO Production Process
12.4 Industry Value Chain Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Cell Therapy CDMO
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cell Therapy CDMO by Type
1.3.1 Overview: Global Cell Therapy CDMO Market Size by Type: 2017 Versus 2021 Versus 2028
1.3.2 Global Cell Therapy CDMO Consumption Value Market Share by Type in 2021
1.3.3 Stem Cell
1.3.4 Non-Stem Cell
1.4 Global Cell Therapy CDMO Market by Application
1.4.1 Overview: Global Cell Therapy CDMO Market Size by Application: 2017 Versus 2021 Versus 2028
1.4.2 Commercial
1.4.3 Academic Research
1.4.4 Others
1.5 Global Cell Therapy CDMO Market Size & Forecast
1.6 Global Cell Therapy CDMO Market Size and Forecast by Region
1.6.1 Global Cell Therapy CDMO Market Size by Region: 2017 VS 2021 VS 2028
1.6.2 Global Cell Therapy CDMO Market Size by Region, (2017-2028)
1.6.3 North America Cell Therapy CDMO Market Size and Prospect (2017-2028)
1.6.4 Europe Cell Therapy CDMO Market Size and Prospect (2017-2028)
1.6.5 Asia-Pacific Cell Therapy CDMO Market Size and Prospect (2017-2028)
1.6.6 South America Cell Therapy CDMO Market Size and Prospect (2017-2028)
1.6.7 Middle East and Africa Cell Therapy CDMO Market Size and Prospect (2017-2028)
2 COMPANY PROFILES
2.1 Charles River
2.1.1 Charles River Details
2.1.2 Charles River Major Business
2.1.3 Charles River Cell Therapy CDMO Product and Solutions
2.1.4 Charles River Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.1.5 Charles River Recent Developments and Future Plans
2.2 The Discovery Labs
2.2.1 The Discovery Labs Details
2.2.2 The Discovery Labs Major Business
2.2.3 The Discovery Labs Cell Therapy CDMO Product and Solutions
2.2.4 The Discovery Labs Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.2.5 The Discovery Labs Recent Developments and Future Plans
2.3 BIOCENTRIQ
2.3.1 BIOCENTRIQ Details
2.3.2 BIOCENTRIQ Major Business
2.3.3 BIOCENTRIQ Cell Therapy CDMO Product and Solutions
2.3.4 BIOCENTRIQ Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.3.5 BIOCENTRIQ Recent Developments and Future Plans
2.4 FUJIFILM Diosynth Biotechnologies
2.4.1 FUJIFILM Diosynth Biotechnologies Details
2.4.2 FUJIFILM Diosynth Biotechnologies Major Business
2.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product and Solutions
2.4.4 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.4.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.5 Exothera
2.5.1 Exothera Details
2.5.2 Exothera Major Business
2.5.3 Exothera Cell Therapy CDMO Product and Solutions
2.5.4 Exothera Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.5.5 Exothera Recent Developments and Future Plans
2.6 WuXi AppTec
2.6.1 WuXi AppTec Details
2.6.2 WuXi AppTec Major Business
2.6.3 WuXi AppTec Cell Therapy CDMO Product and Solutions
2.6.4 WuXi AppTec Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.6.5 WuXi AppTec Recent Developments and Future Plans
2.7 Pharmaron
2.7.1 Pharmaron Details
2.7.2 Pharmaron Major Business
2.7.3 Pharmaron Cell Therapy CDMO Product and Solutions
2.7.4 Pharmaron Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.7.5 Pharmaron Recent Developments and Future Plans
2.8 OBiO
2.8.1 OBiO Details
2.8.2 OBiO Major Business
2.8.3 OBiO Cell Therapy CDMO Product and Solutions
2.8.4 OBiO Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.8.5 OBiO Recent Developments and Future Plans
2.9 Cell Therapies
2.9.1 Cell Therapies Details
2.9.2 Cell Therapies Major Business
2.9.3 Cell Therapies Cell Therapy CDMO Product and Solutions
2.9.4 Cell Therapies Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.9.5 Cell Therapies Recent Developments and Future Plans
2.10 AGC Biologics
2.10.1 AGC Biologics Details
2.10.2 AGC Biologics Major Business
2.10.3 AGC Biologics Cell Therapy CDMO Product and Solutions
2.10.4 AGC Biologics Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.10.5 AGC Biologics Recent Developments and Future Plans
2.11 Cytiva
2.11.1 Cytiva Details
2.11.2 Cytiva Major Business
2.11.3 Cytiva Cell Therapy CDMO Product and Solutions
2.11.4 Cytiva Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.11.5 Cytiva Recent Developments and Future Plans
2.12 Helixmith
2.12.1 Helixmith Details
2.12.2 Helixmith Major Business
2.12.3 Helixmith Cell Therapy CDMO Product and Solutions
2.12.4 Helixmith Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.12.5 Helixmith Recent Developments and Future Plans
2.13 ThermoGenesis
2.13.1 ThermoGenesis Details
2.13.2 ThermoGenesis Major Business
2.13.3 ThermoGenesis Cell Therapy CDMO Product and Solutions
2.13.4 ThermoGenesis Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.13.5 ThermoGenesis Recent Developments and Future Plans
2.14 Anemocyte
2.14.1 Anemocyte Details
2.14.2 Anemocyte Major Business
2.14.3 Anemocyte Cell Therapy CDMO Product and Solutions
2.14.4 Anemocyte Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.14.5 Anemocyte Recent Developments and Future Plans
2.15 Thermo Fisher Scientific
2.15.1 Thermo Fisher Scientific Details
2.15.2 Thermo Fisher Scientific Major Business
2.15.3 Thermo Fisher Scientific Cell Therapy CDMO Product and Solutions
2.15.4 Thermo Fisher Scientific Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.15.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.16 CBM
2.16.1 CBM Details
2.16.2 CBM Major Business
2.16.3 CBM Cell Therapy CDMO Product and Solutions
2.16.4 CBM Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.16.5 CBM Recent Developments and Future Plans
2.17 Bio Elpida
2.17.1 Bio Elpida Details
2.17.2 Bio Elpida Major Business
2.17.3 Bio Elpida Cell Therapy CDMO Product and Solutions
2.17.4 Bio Elpida Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.17.5 Bio Elpida Recent Developments and Future Plans
2.18 Genezen
2.18.1 Genezen Details
2.18.2 Genezen Major Business
2.18.3 Genezen Cell Therapy CDMO Product and Solutions
2.18.4 Genezen Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.18.5 Genezen Recent Developments and Future Plans
2.19 CCRM
2.19.1 CCRM Details
2.19.2 CCRM Major Business
2.19.3 CCRM Cell Therapy CDMO Product and Solutions
2.19.4 CCRM Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.19.5 CCRM Recent Developments and Future Plans
2.20 RoslinCT
2.20.1 RoslinCT Details
2.20.2 RoslinCT Major Business
2.20.3 RoslinCT Cell Therapy CDMO Product and Solutions
2.20.4 RoslinCT Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.20.5 RoslinCT Recent Developments and Future Plans
2.21 GenScript ProBio
2.21.1 GenScript ProBio Details
2.21.2 GenScript ProBio Major Business
2.21.3 GenScript ProBio Cell Therapy CDMO Product and Solutions
2.21.4 GenScript ProBio Cell Therapy CDMO Revenue, Gross Margin and Market Share (2017-2022)
2.21.5 GenScript ProBio Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Cell Therapy CDMO Revenue and Share by Players (2017-2022)
3.2 Market Share Analysis (2021)
3.2.1 Market Share of Cell Therapy CDMO by Company Revenue
3.2.2 Top 3 Cell Therapy CDMO Players Market Share in 2021
3.2.3 Top 6 Cell Therapy CDMO Players Market Share in 2021
3.3 Cell Therapy CDMO Market: Overall Company Footprint Analysis
3.3.1 Cell Therapy CDMO Market: Region Footprint
3.3.2 Cell Therapy CDMO Market: Company Product Type Footprint
3.3.3 Cell Therapy CDMO Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Cell Therapy CDMO Consumption Value and Market Share by Type (2017-2022)
4.2 Global Cell Therapy CDMO Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Cell Therapy CDMO Consumption Value Market Share by Application (2017-2022)
5.2 Global Cell Therapy CDMO Market Forecast by Application (2023-2028)
6 NORTH AMERICA
6.1 North America Cell Therapy CDMO Consumption Value by Type (2017-2028)
6.2 North America Cell Therapy CDMO Consumption Value by Application (2017-2028)
6.3 North America Cell Therapy CDMO Market Size by Country
6.3.1 North America Cell Therapy CDMO Consumption Value by Country (2017-2028)
6.3.2 United States Cell Therapy CDMO Market Size and Forecast (2017-2028)
6.3.3 Canada Cell Therapy CDMO Market Size and Forecast (2017-2028)
6.3.4 Mexico Cell Therapy CDMO Market Size and Forecast (2017-2028)
7 EUROPE
7.1 Europe Cell Therapy CDMO Consumption Value by Type (2017-2028)
7.2 Europe Cell Therapy CDMO Consumption Value by Application (2017-2028)
7.3 Europe Cell Therapy CDMO Market Size by Country
7.3.1 Europe Cell Therapy CDMO Consumption Value by Country (2017-2028)
7.3.2 Germany Cell Therapy CDMO Market Size and Forecast (2017-2028)
7.3.3 France Cell Therapy CDMO Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Cell Therapy CDMO Market Size and Forecast (2017-2028)
7.3.5 Russia Cell Therapy CDMO Market Size and Forecast (2017-2028)
7.3.6 Italy Cell Therapy CDMO Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC
8.1 Asia-Pacific Cell Therapy CDMO Consumption Value by Type (2017-2028)
8.2 Asia-Pacific Cell Therapy CDMO Consumption Value by Application (2017-2028)
8.3 Asia-Pacific Cell Therapy CDMO Market Size by Region
8.3.1 Asia-Pacific Cell Therapy CDMO Consumption Value by Region (2017-2028)
8.3.2 China Cell Therapy CDMO Market Size and Forecast (2017-2028)
8.3.3 Japan Cell Therapy CDMO Market Size and Forecast (2017-2028)
8.3.4 South Korea Cell Therapy CDMO Market Size and Forecast (2017-2028)
8.3.5 India Cell Therapy CDMO Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Cell Therapy CDMO Market Size and Forecast (2017-2028)
8.3.7 Australia Cell Therapy CDMO Market Size and Forecast (2017-2028)
9 SOUTH AMERICA
9.1 South America Cell Therapy CDMO Consumption Value by Type (2017-2028)
9.2 South America Cell Therapy CDMO Consumption Value by Application (2017-2028)
9.3 South America Cell Therapy CDMO Market Size by Country
9.3.1 South America Cell Therapy CDMO Consumption Value by Country (2017-2028)
9.3.2 Brazil Cell Therapy CDMO Market Size and Forecast (2017-2028)
9.3.3 Argentina Cell Therapy CDMO Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cell Therapy CDMO Consumption Value by Type (2017-2028)
10.2 Middle East & Africa Cell Therapy CDMO Consumption Value by Application (2017-2028)
10.3 Middle East & Africa Cell Therapy CDMO Market Size by Country
10.3.1 Middle East & Africa Cell Therapy CDMO Consumption Value by Country (2017-2028)
10.3.2 Turkey Cell Therapy CDMO Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Cell Therapy CDMO Market Size and Forecast (2017-2028)
10.3.4 UAE Cell Therapy CDMO Market Size and Forecast (2017-2028)
11 MARKET DYNAMICS
11.1 Cell Therapy CDMO Market Drivers
11.2 Cell Therapy CDMO Market Restraints
11.3 Cell Therapy CDMO Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 UPSTREAM AND INDUSTRY CHAIN
12.1 Raw Material of Cell Therapy CDMO and Key Suppliers
12.2 Manufacturing Costs Percentage of Cell Therapy CDMO
12.3 Cell Therapy CDMO Production Process
12.4 Industry Value Chain Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Cell Therapy CDMO Consumption Value by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Cell Therapy CDMO Consumption Value by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Cell Therapy CDMO Consumption Value by Region (2017-2022) & (USD Million)
Table 4. Global Cell Therapy CDMO Consumption Value by Region (2023-2028) & (USD Million)
Table 5. Charles River Company Information, Head Office, and Major Competitors
Table 6. Charles River Major Business
Table 7. Charles River Cell Therapy CDMO Product and Solutions
Table 8. Charles River Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 9. Charles River Recent Developments and Future Plans
Table 10. The Discovery Labs Company Information, Head Office, and Major Competitors
Table 11. The Discovery Labs Major Business
Table 12. The Discovery Labs Cell Therapy CDMO Product and Solutions
Table 13. The Discovery Labs Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 14. The Discovery Labs Recent Developments and Future Plans
Table 15. BIOCENTRIQ Company Information, Head Office, and Major Competitors
Table 16. BIOCENTRIQ Major Business
Table 17. BIOCENTRIQ Cell Therapy CDMO Product and Solutions
Table 18. BIOCENTRIQ Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 19. BIOCENTRIQ Recent Developments and Future Plans
Table 20. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 21. FUJIFILM Diosynth Biotechnologies Major Business
Table 22. FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product and Solutions
Table 23. FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 24. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
Table 25. Exothera Company Information, Head Office, and Major Competitors
Table 26. Exothera Major Business
Table 27. Exothera Cell Therapy CDMO Product and Solutions
Table 28. Exothera Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 29. Exothera Recent Developments and Future Plans
Table 30. WuXi AppTec Company Information, Head Office, and Major Competitors
Table 31. WuXi AppTec Major Business
Table 32. WuXi AppTec Cell Therapy CDMO Product and Solutions
Table 33. WuXi AppTec Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 34. WuXi AppTec Recent Developments and Future Plans
Table 35. Pharmaron Company Information, Head Office, and Major Competitors
Table 36. Pharmaron Major Business
Table 37. Pharmaron Cell Therapy CDMO Product and Solutions
Table 38. Pharmaron Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 39. Pharmaron Recent Developments and Future Plans
Table 40. OBiO Company Information, Head Office, and Major Competitors
Table 41. OBiO Major Business
Table 42. OBiO Cell Therapy CDMO Product and Solutions
Table 43. OBiO Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 44. OBiO Recent Developments and Future Plans
Table 45. Cell Therapies Company Information, Head Office, and Major Competitors
Table 46. Cell Therapies Major Business
Table 47. Cell Therapies Cell Therapy CDMO Product and Solutions
Table 48. Cell Therapies Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 49. Cell Therapies Recent Developments and Future Plans
Table 50. AGC Biologics Company Information, Head Office, and Major Competitors
Table 51. AGC Biologics Major Business
Table 52. AGC Biologics Cell Therapy CDMO Product and Solutions
Table 53. AGC Biologics Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 54. AGC Biologics Recent Developments and Future Plans
Table 55. Cytiva Company Information, Head Office, and Major Competitors
Table 56. Cytiva Major Business
Table 57. Cytiva Cell Therapy CDMO Product and Solutions
Table 58. Cytiva Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 59. Cytiva Recent Developments and Future Plans
Table 60. Helixmith Company Information, Head Office, and Major Competitors
Table 61. Helixmith Major Business
Table 62. Helixmith Cell Therapy CDMO Product and Solutions
Table 63. Helixmith Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 64. Helixmith Recent Developments and Future Plans
Table 65. ThermoGenesis Company Information, Head Office, and Major Competitors
Table 66. ThermoGenesis Major Business
Table 67. ThermoGenesis Cell Therapy CDMO Product and Solutions
Table 68. ThermoGenesis Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 69. ThermoGenesis Recent Developments and Future Plans
Table 70. Anemocyte Company Information, Head Office, and Major Competitors
Table 71. Anemocyte Major Business
Table 72. Anemocyte Cell Therapy CDMO Product and Solutions
Table 73. Anemocyte Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 74. Anemocyte Recent Developments and Future Plans
Table 75. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 76. Thermo Fisher Scientific Major Business
Table 77. Thermo Fisher Scientific Cell Therapy CDMO Product and Solutions
Table 78. Thermo Fisher Scientific Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 79. Thermo Fisher Scientific Recent Developments and Future Plans
Table 80. CBM Company Information, Head Office, and Major Competitors
Table 81. CBM Major Business
Table 82. CBM Cell Therapy CDMO Product and Solutions
Table 83. CBM Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 84. CBM Recent Developments and Future Plans
Table 85. Bio Elpida Company Information, Head Office, and Major Competitors
Table 86. Bio Elpida Major Business
Table 87. Bio Elpida Cell Therapy CDMO Product and Solutions
Table 88. Bio Elpida Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Bio Elpida Recent Developments and Future Plans
Table 90. Genezen Company Information, Head Office, and Major Competitors
Table 91. Genezen Major Business
Table 92. Genezen Cell Therapy CDMO Product and Solutions
Table 93. Genezen Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 94. Genezen Recent Developments and Future Plans
Table 95. CCRM Company Information, Head Office, and Major Competitors
Table 96. CCRM Major Business
Table 97. CCRM Cell Therapy CDMO Product and Solutions
Table 98. CCRM Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 99. CCRM Recent Developments and Future Plans
Table 100. RoslinCT Company Information, Head Office, and Major Competitors
Table 101. RoslinCT Major Business
Table 102. RoslinCT Cell Therapy CDMO Product and Solutions
Table 103. RoslinCT Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 104. RoslinCT Recent Developments and Future Plans
Table 105. GenScript ProBio Company Information, Head Office, and Major Competitors
Table 106. GenScript ProBio Major Business
Table 107. GenScript ProBio Cell Therapy CDMO Product and Solutions
Table 108. GenScript ProBio Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 109. GenScript ProBio Recent Developments and Future Plans
Table 110. Global Cell Therapy CDMO Revenue (USD Million) by Players (2017-2022)
Table 111. Global Cell Therapy CDMO Revenue Share by Players (2017-2022)
Table 112. Breakdown of Cell Therapy CDMO by Company Type (Tier 1, Tier 2, and Tier 3)
Table 113. Market Position of Players in Cell Therapy CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 114. Head Office of Key Cell Therapy CDMO Players
Table 115. Cell Therapy CDMO Market: Company Product Type Footprint
Table 116. Cell Therapy CDMO Market: Company Product Application Footprint
Table 117. Cell Therapy CDMO New Market Entrants and Barriers to Market Entry
Table 118. Cell Therapy CDMO Mergers, Acquisition, Agreements, and Collaborations
Table 119. Global Cell Therapy CDMO Consumption Value (USD Million) by Type (2017-2022)
Table 120. Global Cell Therapy CDMO Consumption Value Share by Type (2017-2022)
Table 121. Global Cell Therapy CDMO Consumption Value Forecast by Type (2023-2028)
Table 122. Global Cell Therapy CDMO Consumption Value by Application (2017-2022)
Table 123. Global Cell Therapy CDMO Consumption Value Forecast by Application (2023-2028)
Table 124. North America Cell Therapy CDMO Consumption Value by Type (2017-2022) & (USD Million)
Table 125. North America Cell Therapy CDMO Consumption Value by Type (2023-2028) & (USD Million)
Table 126. North America Cell Therapy CDMO Consumption Value by Application (2017-2022) & (USD Million)
Table 127. North America Cell Therapy CDMO Consumption Value by Application (2023-2028) & (USD Million)
Table 128. North America Cell Therapy CDMO Consumption Value by Country (2017-2022) & (USD Million)
Table 129. North America Cell Therapy CDMO Consumption Value by Country (2023-2028) & (USD Million)
Table 130. Europe Cell Therapy CDMO Consumption Value by Type (2017-2022) & (USD Million)
Table 131. Europe Cell Therapy CDMO Consumption Value by Type (2023-2028) & (USD Million)
Table 132. Europe Cell Therapy CDMO Consumption Value by Application (2017-2022) & (USD Million)
Table 133. Europe Cell Therapy CDMO Consumption Value by Application (2023-2028) & (USD Million)
Table 134. Europe Cell Therapy CDMO Consumption Value by Country (2017-2022) & (USD Million)
Table 135. Europe Cell Therapy CDMO Consumption Value by Country (2023-2028) & (USD Million)
Table 136. Asia-Pacific Cell Therapy CDMO Consumption Value by Type (2017-2022) & (USD Million)
Table 137. Asia-Pacific Cell Therapy CDMO Consumption Value by Type (2023-2028) & (USD Million)
Table 138. Asia-Pacific Cell Therapy CDMO Consumption Value by Application (2017-2022) & (USD Million)
Table 139. Asia-Pacific Cell Therapy CDMO Consumption Value by Application (2023-2028) & (USD Million)
Table 140. Asia-Pacific Cell Therapy CDMO Consumption Value by Region (2017-2022) & (USD Million)
Table 141. Asia-Pacific Cell Therapy CDMO Consumption Value by Region (2023-2028) & (USD Million)
Table 142. South America Cell Therapy CDMO Consumption Value by Type (2017-2022) & (USD Million)
Table 143. South America Cell Therapy CDMO Consumption Value by Type (2023-2028) & (USD Million)
Table 144. South America Cell Therapy CDMO Consumption Value by Application (2017-2022) & (USD Million)
Table 145. South America Cell Therapy CDMO Consumption Value by Application (2023-2028) & (USD Million)
Table 146. South America Cell Therapy CDMO Consumption Value by Country (2017-2022) & (USD Million)
Table 147. South America Cell Therapy CDMO Consumption Value by Country (2023-2028) & (USD Million)
Table 148. Middle East & Africa Cell Therapy CDMO Consumption Value by Type (2017-2022) & (USD Million)
Table 149. Middle East & Africa Cell Therapy CDMO Consumption Value by Type (2023-2028) & (USD Million)
Table 150. Middle East & Africa Cell Therapy CDMO Consumption Value by Application (2017-2022) & (USD Million)
Table 151. Middle East & Africa Cell Therapy CDMO Consumption Value by Application (2023-2028) & (USD Million)
Table 152. Middle East & Africa Cell Therapy CDMO Consumption Value by Country (2017-2022) & (USD Million)
Table 153. Middle East & Africa Cell Therapy CDMO Consumption Value by Country (2023-2028) & (USD Million)
Table 154. Cell Therapy CDMO Raw Material
Table 155. Key Suppliers of Cell Therapy CDMO Raw Materials
Table 1. Global Cell Therapy CDMO Consumption Value by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Cell Therapy CDMO Consumption Value by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Cell Therapy CDMO Consumption Value by Region (2017-2022) & (USD Million)
Table 4. Global Cell Therapy CDMO Consumption Value by Region (2023-2028) & (USD Million)
Table 5. Charles River Company Information, Head Office, and Major Competitors
Table 6. Charles River Major Business
Table 7. Charles River Cell Therapy CDMO Product and Solutions
Table 8. Charles River Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 9. Charles River Recent Developments and Future Plans
Table 10. The Discovery Labs Company Information, Head Office, and Major Competitors
Table 11. The Discovery Labs Major Business
Table 12. The Discovery Labs Cell Therapy CDMO Product and Solutions
Table 13. The Discovery Labs Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 14. The Discovery Labs Recent Developments and Future Plans
Table 15. BIOCENTRIQ Company Information, Head Office, and Major Competitors
Table 16. BIOCENTRIQ Major Business
Table 17. BIOCENTRIQ Cell Therapy CDMO Product and Solutions
Table 18. BIOCENTRIQ Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 19. BIOCENTRIQ Recent Developments and Future Plans
Table 20. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 21. FUJIFILM Diosynth Biotechnologies Major Business
Table 22. FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product and Solutions
Table 23. FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 24. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
Table 25. Exothera Company Information, Head Office, and Major Competitors
Table 26. Exothera Major Business
Table 27. Exothera Cell Therapy CDMO Product and Solutions
Table 28. Exothera Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 29. Exothera Recent Developments and Future Plans
Table 30. WuXi AppTec Company Information, Head Office, and Major Competitors
Table 31. WuXi AppTec Major Business
Table 32. WuXi AppTec Cell Therapy CDMO Product and Solutions
Table 33. WuXi AppTec Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 34. WuXi AppTec Recent Developments and Future Plans
Table 35. Pharmaron Company Information, Head Office, and Major Competitors
Table 36. Pharmaron Major Business
Table 37. Pharmaron Cell Therapy CDMO Product and Solutions
Table 38. Pharmaron Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 39. Pharmaron Recent Developments and Future Plans
Table 40. OBiO Company Information, Head Office, and Major Competitors
Table 41. OBiO Major Business
Table 42. OBiO Cell Therapy CDMO Product and Solutions
Table 43. OBiO Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 44. OBiO Recent Developments and Future Plans
Table 45. Cell Therapies Company Information, Head Office, and Major Competitors
Table 46. Cell Therapies Major Business
Table 47. Cell Therapies Cell Therapy CDMO Product and Solutions
Table 48. Cell Therapies Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 49. Cell Therapies Recent Developments and Future Plans
Table 50. AGC Biologics Company Information, Head Office, and Major Competitors
Table 51. AGC Biologics Major Business
Table 52. AGC Biologics Cell Therapy CDMO Product and Solutions
Table 53. AGC Biologics Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 54. AGC Biologics Recent Developments and Future Plans
Table 55. Cytiva Company Information, Head Office, and Major Competitors
Table 56. Cytiva Major Business
Table 57. Cytiva Cell Therapy CDMO Product and Solutions
Table 58. Cytiva Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 59. Cytiva Recent Developments and Future Plans
Table 60. Helixmith Company Information, Head Office, and Major Competitors
Table 61. Helixmith Major Business
Table 62. Helixmith Cell Therapy CDMO Product and Solutions
Table 63. Helixmith Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 64. Helixmith Recent Developments and Future Plans
Table 65. ThermoGenesis Company Information, Head Office, and Major Competitors
Table 66. ThermoGenesis Major Business
Table 67. ThermoGenesis Cell Therapy CDMO Product and Solutions
Table 68. ThermoGenesis Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 69. ThermoGenesis Recent Developments and Future Plans
Table 70. Anemocyte Company Information, Head Office, and Major Competitors
Table 71. Anemocyte Major Business
Table 72. Anemocyte Cell Therapy CDMO Product and Solutions
Table 73. Anemocyte Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 74. Anemocyte Recent Developments and Future Plans
Table 75. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 76. Thermo Fisher Scientific Major Business
Table 77. Thermo Fisher Scientific Cell Therapy CDMO Product and Solutions
Table 78. Thermo Fisher Scientific Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 79. Thermo Fisher Scientific Recent Developments and Future Plans
Table 80. CBM Company Information, Head Office, and Major Competitors
Table 81. CBM Major Business
Table 82. CBM Cell Therapy CDMO Product and Solutions
Table 83. CBM Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 84. CBM Recent Developments and Future Plans
Table 85. Bio Elpida Company Information, Head Office, and Major Competitors
Table 86. Bio Elpida Major Business
Table 87. Bio Elpida Cell Therapy CDMO Product and Solutions
Table 88. Bio Elpida Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Bio Elpida Recent Developments and Future Plans
Table 90. Genezen Company Information, Head Office, and Major Competitors
Table 91. Genezen Major Business
Table 92. Genezen Cell Therapy CDMO Product and Solutions
Table 93. Genezen Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 94. Genezen Recent Developments and Future Plans
Table 95. CCRM Company Information, Head Office, and Major Competitors
Table 96. CCRM Major Business
Table 97. CCRM Cell Therapy CDMO Product and Solutions
Table 98. CCRM Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 99. CCRM Recent Developments and Future Plans
Table 100. RoslinCT Company Information, Head Office, and Major Competitors
Table 101. RoslinCT Major Business
Table 102. RoslinCT Cell Therapy CDMO Product and Solutions
Table 103. RoslinCT Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 104. RoslinCT Recent Developments and Future Plans
Table 105. GenScript ProBio Company Information, Head Office, and Major Competitors
Table 106. GenScript ProBio Major Business
Table 107. GenScript ProBio Cell Therapy CDMO Product and Solutions
Table 108. GenScript ProBio Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 109. GenScript ProBio Recent Developments and Future Plans
Table 110. Global Cell Therapy CDMO Revenue (USD Million) by Players (2017-2022)
Table 111. Global Cell Therapy CDMO Revenue Share by Players (2017-2022)
Table 112. Breakdown of Cell Therapy CDMO by Company Type (Tier 1, Tier 2, and Tier 3)
Table 113. Market Position of Players in Cell Therapy CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 114. Head Office of Key Cell Therapy CDMO Players
Table 115. Cell Therapy CDMO Market: Company Product Type Footprint
Table 116. Cell Therapy CDMO Market: Company Product Application Footprint
Table 117. Cell Therapy CDMO New Market Entrants and Barriers to Market Entry
Table 118. Cell Therapy CDMO Mergers, Acquisition, Agreements, and Collaborations
Table 119. Global Cell Therapy CDMO Consumption Value (USD Million) by Type (2017-2022)
Table 120. Global Cell Therapy CDMO Consumption Value Share by Type (2017-2022)
Table 121. Global Cell Therapy CDMO Consumption Value Forecast by Type (2023-2028)
Table 122. Global Cell Therapy CDMO Consumption Value by Application (2017-2022)
Table 123. Global Cell Therapy CDMO Consumption Value Forecast by Application (2023-2028)
Table 124. North America Cell Therapy CDMO Consumption Value by Type (2017-2022) & (USD Million)
Table 125. North America Cell Therapy CDMO Consumption Value by Type (2023-2028) & (USD Million)
Table 126. North America Cell Therapy CDMO Consumption Value by Application (2017-2022) & (USD Million)
Table 127. North America Cell Therapy CDMO Consumption Value by Application (2023-2028) & (USD Million)
Table 128. North America Cell Therapy CDMO Consumption Value by Country (2017-2022) & (USD Million)
Table 129. North America Cell Therapy CDMO Consumption Value by Country (2023-2028) & (USD Million)
Table 130. Europe Cell Therapy CDMO Consumption Value by Type (2017-2022) & (USD Million)
Table 131. Europe Cell Therapy CDMO Consumption Value by Type (2023-2028) & (USD Million)
Table 132. Europe Cell Therapy CDMO Consumption Value by Application (2017-2022) & (USD Million)
Table 133. Europe Cell Therapy CDMO Consumption Value by Application (2023-2028) & (USD Million)
Table 134. Europe Cell Therapy CDMO Consumption Value by Country (2017-2022) & (USD Million)
Table 135. Europe Cell Therapy CDMO Consumption Value by Country (2023-2028) & (USD Million)
Table 136. Asia-Pacific Cell Therapy CDMO Consumption Value by Type (2017-2022) & (USD Million)
Table 137. Asia-Pacific Cell Therapy CDMO Consumption Value by Type (2023-2028) & (USD Million)
Table 138. Asia-Pacific Cell Therapy CDMO Consumption Value by Application (2017-2022) & (USD Million)
Table 139. Asia-Pacific Cell Therapy CDMO Consumption Value by Application (2023-2028) & (USD Million)
Table 140. Asia-Pacific Cell Therapy CDMO Consumption Value by Region (2017-2022) & (USD Million)
Table 141. Asia-Pacific Cell Therapy CDMO Consumption Value by Region (2023-2028) & (USD Million)
Table 142. South America Cell Therapy CDMO Consumption Value by Type (2017-2022) & (USD Million)
Table 143. South America Cell Therapy CDMO Consumption Value by Type (2023-2028) & (USD Million)
Table 144. South America Cell Therapy CDMO Consumption Value by Application (2017-2022) & (USD Million)
Table 145. South America Cell Therapy CDMO Consumption Value by Application (2023-2028) & (USD Million)
Table 146. South America Cell Therapy CDMO Consumption Value by Country (2017-2022) & (USD Million)
Table 147. South America Cell Therapy CDMO Consumption Value by Country (2023-2028) & (USD Million)
Table 148. Middle East & Africa Cell Therapy CDMO Consumption Value by Type (2017-2022) & (USD Million)
Table 149. Middle East & Africa Cell Therapy CDMO Consumption Value by Type (2023-2028) & (USD Million)
Table 150. Middle East & Africa Cell Therapy CDMO Consumption Value by Application (2017-2022) & (USD Million)
Table 151. Middle East & Africa Cell Therapy CDMO Consumption Value by Application (2023-2028) & (USD Million)
Table 152. Middle East & Africa Cell Therapy CDMO Consumption Value by Country (2017-2022) & (USD Million)
Table 153. Middle East & Africa Cell Therapy CDMO Consumption Value by Country (2023-2028) & (USD Million)
Table 154. Cell Therapy CDMO Raw Material
Table 155. Key Suppliers of Cell Therapy CDMO Raw Materials
LIST OF FIGURES
Figure 1. Cell Therapy CDMO Picture
Figure 2. Global Cell Therapy CDMO Consumption Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 3. Global Cell Therapy CDMO Consumption Value Market Share by Type in 2021
Figure 4. Stem Cell
Figure 5. Non-Stem Cell
Figure 6. Global Cell Therapy CDMO Consumption Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 7. Cell Therapy CDMO Consumption Value Market Share by Application in 2021
Figure 8. Commercial Picture
Figure 9. Academic Research Picture
Figure 10. Others Picture
Figure 11. Global Cell Therapy CDMO Consumption Value, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Cell Therapy CDMO Consumption Value and Forecast (2017-2028) & (USD Million)
Figure 13. Global Market Cell Therapy CDMO Consumption Value (USD Million) Comparison by Region (2017 VS 2021 VS 2028)
Figure 14. Global Cell Therapy CDMO Consumption Value Market Share by Region (2017-2028)
Figure 15. Global Cell Therapy CDMO Consumption Value Market Share by Region in 2021
Figure 16. North America Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 17. Europe Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 18. Asia-Pacific Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 19. South America Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 20. Middle East and Africa Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 21. Global Cell Therapy CDMO Revenue Share by Players in 2021
Figure 22. Cell Therapy CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 23. Global Top 3 Players Cell Therapy CDMO Market Share in 2021
Figure 24. Global Top 6 Players Cell Therapy CDMO Market Share in 2021
Figure 25. Global Cell Therapy CDMO Consumption Value Share by Type (2017-2022)
Figure 26. Global Cell Therapy CDMO Market Share Forecast by Type (2023-2028)
Figure 27. Global Cell Therapy CDMO Consumption Value Share by Application (2017-2022)
Figure 28. Global Cell Therapy CDMO Market Share Forecast by Application (2023-2028)
Figure 29. North America Cell Therapy CDMO Consumption Value Market Share by Type (2017-2028)
Figure 30. North America Cell Therapy CDMO Consumption Value Market Share by Application (2017-2028)
Figure 31. North America Cell Therapy CDMO Consumption Value Market Share by Country (2017-2028)
Figure 32. United States Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 33. Canada Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 34. Mexico Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 35. Europe Cell Therapy CDMO Consumption Value Market Share by Type (2017-2028)
Figure 36. Europe Cell Therapy CDMO Consumption Value Market Share by Application (2017-2028)
Figure 37. Europe Cell Therapy CDMO Consumption Value Market Share by Country (2017-2028)
Figure 38. Germany Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 39. France Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 40. United Kingdom Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 41. Russia Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 42. Italy Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 43. Asia-Pacific Cell Therapy CDMO Consumption Value Market Share by Type (2017-2028)
Figure 44. Asia-Pacific Cell Therapy CDMO Consumption Value Market Share by Application (2017-2028)
Figure 45. Asia-Pacific Cell Therapy CDMO Consumption Value Market Share by Region (2017-2028)
Figure 46. China Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 47. Japan Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 48. South Korea Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 49. India Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 50. Southeast Asia Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 51. Australia Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 52. South America Cell Therapy CDMO Consumption Value Market Share by Type (2017-2028)
Figure 53. South America Cell Therapy CDMO Consumption Value Market Share by Application (2017-2028)
Figure 54. South America Cell Therapy CDMO Consumption Value Market Share by Country (2017-2028)
Figure 55. Brazil Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 56. Argentina Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 57. Middle East and Africa Cell Therapy CDMO Consumption Value Market Share by Type (2017-2028)
Figure 58. Middle East and Africa Cell Therapy CDMO Consumption Value Market Share by Application (2017-2028)
Figure 59. Middle East and Africa Cell Therapy CDMO Consumption Value Market Share by Country (2017-2028)
Figure 60. Turkey Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 61. Saudi Arabia Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 62. UAE Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 63. Cell Therapy CDMO Market Drivers
Figure 64. Cell Therapy CDMO Market Restraints
Figure 65. Cell Therapy CDMO Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Cell Therapy CDMO in 2021
Figure 68. Manufacturing Process Analysis of Cell Therapy CDMO
Figure 69. Cell Therapy CDMO Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Cell Therapy CDMO Picture
Figure 2. Global Cell Therapy CDMO Consumption Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 3. Global Cell Therapy CDMO Consumption Value Market Share by Type in 2021
Figure 4. Stem Cell
Figure 5. Non-Stem Cell
Figure 6. Global Cell Therapy CDMO Consumption Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 7. Cell Therapy CDMO Consumption Value Market Share by Application in 2021
Figure 8. Commercial Picture
Figure 9. Academic Research Picture
Figure 10. Others Picture
Figure 11. Global Cell Therapy CDMO Consumption Value, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Cell Therapy CDMO Consumption Value and Forecast (2017-2028) & (USD Million)
Figure 13. Global Market Cell Therapy CDMO Consumption Value (USD Million) Comparison by Region (2017 VS 2021 VS 2028)
Figure 14. Global Cell Therapy CDMO Consumption Value Market Share by Region (2017-2028)
Figure 15. Global Cell Therapy CDMO Consumption Value Market Share by Region in 2021
Figure 16. North America Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 17. Europe Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 18. Asia-Pacific Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 19. South America Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 20. Middle East and Africa Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 21. Global Cell Therapy CDMO Revenue Share by Players in 2021
Figure 22. Cell Therapy CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 23. Global Top 3 Players Cell Therapy CDMO Market Share in 2021
Figure 24. Global Top 6 Players Cell Therapy CDMO Market Share in 2021
Figure 25. Global Cell Therapy CDMO Consumption Value Share by Type (2017-2022)
Figure 26. Global Cell Therapy CDMO Market Share Forecast by Type (2023-2028)
Figure 27. Global Cell Therapy CDMO Consumption Value Share by Application (2017-2022)
Figure 28. Global Cell Therapy CDMO Market Share Forecast by Application (2023-2028)
Figure 29. North America Cell Therapy CDMO Consumption Value Market Share by Type (2017-2028)
Figure 30. North America Cell Therapy CDMO Consumption Value Market Share by Application (2017-2028)
Figure 31. North America Cell Therapy CDMO Consumption Value Market Share by Country (2017-2028)
Figure 32. United States Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 33. Canada Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 34. Mexico Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 35. Europe Cell Therapy CDMO Consumption Value Market Share by Type (2017-2028)
Figure 36. Europe Cell Therapy CDMO Consumption Value Market Share by Application (2017-2028)
Figure 37. Europe Cell Therapy CDMO Consumption Value Market Share by Country (2017-2028)
Figure 38. Germany Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 39. France Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 40. United Kingdom Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 41. Russia Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 42. Italy Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 43. Asia-Pacific Cell Therapy CDMO Consumption Value Market Share by Type (2017-2028)
Figure 44. Asia-Pacific Cell Therapy CDMO Consumption Value Market Share by Application (2017-2028)
Figure 45. Asia-Pacific Cell Therapy CDMO Consumption Value Market Share by Region (2017-2028)
Figure 46. China Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 47. Japan Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 48. South Korea Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 49. India Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 50. Southeast Asia Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 51. Australia Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 52. South America Cell Therapy CDMO Consumption Value Market Share by Type (2017-2028)
Figure 53. South America Cell Therapy CDMO Consumption Value Market Share by Application (2017-2028)
Figure 54. South America Cell Therapy CDMO Consumption Value Market Share by Country (2017-2028)
Figure 55. Brazil Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 56. Argentina Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 57. Middle East and Africa Cell Therapy CDMO Consumption Value Market Share by Type (2017-2028)
Figure 58. Middle East and Africa Cell Therapy CDMO Consumption Value Market Share by Application (2017-2028)
Figure 59. Middle East and Africa Cell Therapy CDMO Consumption Value Market Share by Country (2017-2028)
Figure 60. Turkey Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 61. Saudi Arabia Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 62. UAE Cell Therapy CDMO Consumption Value (2017-2028) & (USD Million)
Figure 63. Cell Therapy CDMO Market Drivers
Figure 64. Cell Therapy CDMO Market Restraints
Figure 65. Cell Therapy CDMO Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Cell Therapy CDMO in 2021
Figure 68. Manufacturing Process Analysis of Cell Therapy CDMO
Figure 69. Cell Therapy CDMO Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
